StemBioSys
Latest round
- Series A
Last raised
- Apr 2015
Total raised
- $8M
Investors
- 1
About StemBioSys
StemBioSys, Inc.Founded in 2010 and headquartered in San Antonio, US, StemBioSys, Inc. specializes in advanced cell culture solutions.39 mn.StemBioSys, Inc. specializes in innovative cell culture technologies, with its primary product offerings centered around the CELLvo™ Matrix Plus. This next-generation cellular matrix technology is designed to create a biologically relevant environment that mimics the native extracellular matrix, thereby supporting the maturation and functionality of various cell types, particularly induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). The CELLvo™ Matrix Plus facilitates the generation of structurally mature cardiomyocytes, which are crucial for preclinical drug safety testing and cardiotoxicity screening. The products are tailored for use in research settings, primarily targeting biopharmaceutical companies, academic institutions, and other entities involved in cardiac research and drug development.The revenue generation model for StemBioSys is primarily structured around the direct sale of CELLvo™ Matrix Plus and related products to research institutions and pharmaceutical companies. Transactions typically involve one-time purchases of products, with options for custom coating services for cell culture plates and flasks. The pricing structure for CELLvo™ Matrix products reflects their premium positioning in the market, facilitating high-throughput testing and research applications. The company’s clientele includes both academic and corporate customers who engage in B2B transactions, often purchasing in bulk to meet the needs of ongoing research projects.StemBioSys, Inc. The company is actively exploring opportunities to expand its market reach into Europe and Asia by 2023, focusing on partnerships with biopharmaceutical companies and academic research institutes. These strategic initiatives aim to address the growing global demand for specialized cell culture technologies.
Who invested in StemBioSys
1 investor across 1 round
See all investors in StemBioSys
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 14, 2015
Amount
$8M
Investors
Questions about StemBioSys
Who invested in StemBioSys?
StemBioSys has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has StemBioSys raised?
StemBioSys has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did StemBioSys last raise money?
StemBioSys's most recent round on record is a Series A, in Apr 2015.
What does StemBioSys do?
StemBioSys is a biotechnology company.
Where is StemBioSys headquartered?
StemBioSys is headquartered in San Antonio, US.
Which VCs invest in companies like StemBioSys?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at StemBioSys's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like StemBioSys? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.